KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Revenue: 2009-2024

Historic Revenue for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Dec 2024 value amounting to $4.1 billion.

  • Jazz Pharmaceuticals' Revenue rose 6.74% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 billion, marking a year-over-year increase of 4.37%. This contributed to the annual value of $4.1 billion for FY2024, which is 6.12% up from last year.
  • According to the latest figures from FY2024, Jazz Pharmaceuticals' Revenue is $4.1 billion, which was up 6.12% from $3.8 billion recorded in FY2023.
  • In the past 5 years, Jazz Pharmaceuticals' Revenue registered a high of $4.1 billion during FY2024, and its lowest value of $2.4 billion during FY2020.
  • In the last 3 years, Jazz Pharmaceuticals' Revenue had a median value of $3.8 billion in 2023 and averaged $3.9 billion.
  • Data for Jazz Pharmaceuticals' Revenue shows a peak YoY surged of 30.91% (in 2021) over the last 5 years.
  • Over the past 5 years, Jazz Pharmaceuticals' Revenue (Yearly) stood at $2.4 billion in 2020, then surged by 30.91% to $3.1 billion in 2021, then increased by 18.26% to $3.7 billion in 2022, then rose by 4.78% to $3.8 billion in 2023, then climbed by 6.12% to $4.1 billion in 2024.